Pharmaceutical AND Chemical Pharmaceutical Import Profile — Zimbabwe (DGFT 2022–2026)

Name: Pharmaceutical AND Chemical Pharmaceutical Import Records from India — 2 Products, $1.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Pharmaceutical AND Chemical — Pharmaceutical Importer Profile (2026) | 2 Products, $1.7M Trade | TransData Nexus

Pharmaceutical AND Chemical

Pharmaceutical Importer · Zimbabwe · Cardiovascular Focus · $1.7M Total Trade · DGFT Verified

Pharmaceutical AND Chemical is a pharmaceutical importer based in Zimbabwe with a total trade value of $1.7M across 2 products in 2 therapeutic categories. Based on 35 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Pharmaceutical AND Chemical sources from 22 verified Indian suppliers, with Torrent Pharmaceuticals Limited accounting for 35.0% of imports.

Pharmaceutical AND Chemical — Import Portfolio & Supplier Network

Pharmaceutical AND Chemical import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Pharmaceutical AND Chemical?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Torrent Pharmaceuticals Limited	$5.9M	434	35.0%
Laborate Pharmaceutical India Limited	$2.8M	123	16.7%
Intas Pharmaceuticals Limited

What Formulations Does Pharmaceutical AND Chemical Import?

Formulation	Value	Ships
Calcigard retard tablet (nifedipine 20MG	$476.4K	11
Calcigard retard tablet ( nifedipine 20MG sustained release ) nos size 2x5x10	$414.1K	9
1-980 kold time tabletparacetamol BP 500MG+caffeine BP 25MG +pseudoephedrine hcl BP 30MG+chlorphenamine maleate BP 2MG	$400.0K	8
Calcigard retard tablet(nifedipine 20MG	$312.1K	8
Calcigard retard tablet nifedipine 20MG sustained release nos size 2x5x10	$288.8K	6
Calcigard retard tabletnifedipine 20mgsustained releasenos=2x5x10 TAB	$200.0K	4
Torrent sodium valproate 200 tablet	$143.6K	5
Calcigard retard tablet (nifedipine 20mgsustained release)nos=2x5x10	$137.2K	6
Calcigard retard tablet(nifedipine 20mgsustained release) (nos=2x5x10 TAB)	$124.8K	3
Diclofenac tablets(Gastro-Resistant	$123.8K	4
Calcigard retard tablet (nifedipine 20mgsustained release) nos size 2x5x10	$100.0K	2
Ceftriaxone for injection USP (sefixi 1000 ) (as per invoice)	$100.0K	2
Celebib 200 celecoxib 200MG capsules batch no 14250886a mfg dt 04 2025 exp dt 03	$100.0K	2
Calcigard retard tabletnifedipine 20MG	$95.8K	2
Latanoprost and timolol eye drops 2.5ML	$94.0K	3

Pharmaceutical AND Chemical imports 942 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Nifedipine	Cardiovascular	$1.5M	32	5.1%	3
2	Tetracycline	Antibiotics	$130.1K	3	0.8%	15

Pharmaceutical AND Chemical imports 2 pharmaceutical products across 2 categories into Zimbabwe totaling $1.7M.

Pharmaceutical AND Chemical — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Pharmaceutical and Chemical Distributors (Pty. Ltd.) (PCD) is a leading full-line distributor of pharmaceutical and healthcare products in Zimbabwe, established in 1993. Headquartered at 33 Watts Road, New Ardbennie, Harare, the company has grown from a team of five to over 100 dedicated professionals. PCD plays a pivotal role in Zimbabwe's healthcare delivery system by providing a diversified range of high-quality products to both private and public health sectors. Their mission is to make quality healthcare products accessible to all communities through excellent service and close partnerships with stakeholders. (pcd.co.zw)

2Distribution Network

PCD's distribution network is centralized at their Harare facility, strategically located to serve the entire Zimbabwean market. The company has invested in state-of-the-art facilities to ensure efficient storage and distribution of pharmaceutical products. While specific warehouse locations beyond Harare are not detailed, PCD's extensive experience and infrastructure suggest a robust logistics capability to meet the needs of healthcare facilities nationwide. (pcd.co.zw)

3Industry Role

As a primary wholesaler, PCD sources a wide array of pharmaceutical and healthcare products from reputable manufacturers, including those in India. Their clientele comprises hospitals, clinics, pharmacies, and medical laboratories across Zimbabwe, serving both the private and public sectors. PCD's role is crucial in ensuring the availability of essential medicines and healthcare products throughout the country. (pcd.co.zw)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Pharmaceutical AND Chemical

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

PCD's sourcing strategy is heavily concentrated on Indian suppliers, with a total import value of $1.7 million USD from India over 35 shipments. The top five products imported are Nifedipine ($1.5 million, 5.1% share) and Tetracycline ($130,000, 0.8% share), indicating a focus on cardiovascular and antibiotic therapies. This concentration suggests a strategic choice to leverage India's competitive pricing and quality standards. The consistent shipment data over the years indicates a stable and reliable relationship with Indian suppliers, mitigating risks associated with single-source dependency.

2Supply Chain Resilience

PCD's supply chain resilience is bolstered by its diversified portfolio of 942 unique formulations, reducing dependency on any single product. The company's established relationships with 22 verified Indian suppliers, including major players like Torrent Pharmaceuticals Limited and Intas Pharmaceuticals Limited, further enhance supply chain stability. While specific backup suppliers are not detailed, the breadth of PCD's supplier base and product range suggests a well-prepared supply chain capable of adapting to market fluctuations.

3Strategic Implications

Importing Pharmaceuticals into Zimbabwe — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Zimbabwe

1Regulatory Authority & Framework

The Medicines Control Authority of Zimbabwe (MCAZ) is the primary regulatory body overseeing the importation and distribution of pharmaceutical products in Zimbabwe. Key legislation governing pharmaceutical imports includes the Medicines and Allied Substances Control (Import and Export of Medicines) Regulations, 2008 (S.I. No. 57 of 2008), which outlines the requirements for importing registered medicines. The marketing authorization pathway for Indian generics involves obtaining approval from MCAZ, ensuring compliance with local standards and regulations. (mcaz.co.zw)

2Import Licensing & GMP

Importers must obtain an import permit for each shipment of registered medicines, as stipulated by MCAZ regulations. The import permit application must be accompanied by a fee and a verification fee of 0.05% of the Cost Insurance and Freight (CIF) value for each consignment before it can be cleared for sale. Recognized Good Manufacturing Practice (GMP) certificates, such as EU GMP, WHO GMP, or PIC/S, are essential for ensuring product quality and regulatory compliance. Additionally, importers must hold a wholesale distribution authorization to legally distribute pharmaceutical products within Zimbabwe. (mcaz.co.zw)

Quality & Labeling

Pharmaceutical AND Chemical — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

PCD's focus on importing cardiovascular and antibiotic therapies aligns with the prevalent health concerns in Zimbabwe, where non-communicable diseases and infectious diseases are significant public health issues. The high import value of Nifedipine indicates a substantial demand for hypertension management, while the inclusion of Tetracycline reflects the ongoing need for effective antibiotics. This strategic product selection ensures that PCD meets critical healthcare needs within the country.

2Sourcing Profile

PCD's sourcing strategy emphasizes generic drugs, particularly those manufactured in India, known for their cost-effectiveness and adherence to international quality standards. The company's preference for finished pharmaceutical formulations over raw Active Pharmaceutical Ingredients (APIs) allows for streamlined distribution and immediate market availability. India's established pharmaceutical industry fits well into PCD's procurement strategy, providing a reliable source of high-quality products.

3Market Positioning

With a diverse product mix, PCD serves multiple segments of the Zimbabwean pharmaceutical market, including retail pharmacies, hospitals, government tenders, and wholesale distribution. The company's extensive distribution network and comprehensive product portfolio enable it to meet the varied needs of healthcare providers and patients across the country.

Seller's Guide — How to Become a Supplier to Pharmaceutical AND Chemical

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Zimbabwean market through partnerships with distributors like PCD. Gaps in PCD's current sourcing include potential shortages in specific therapeutic areas or product forms. Indian exporters can explore these opportunities by offering products that complement PCD's existing portfolio and meet the evolving healthcare needs of Zimbabwe.

2Requirements & Qualifications

Indian exporters aiming to supply PCD and the broader Zimbabwean market must ensure their products are registered with MCAZ and comply with local import regulations. Possessing recognized GMP certifications, such as EU GMP, WHO GMP, or PIC/S, is crucial for demonstrating product quality and regulatory compliance. Additionally, exporters should be prepared to provide detailed product information, including labeling in English, to meet MCAZ's requirements.

3How to Approach

To establish a relationship with PCD, Indian exporters should initiate contact through formal channels, providing comprehensive product portfolios and demonstrating compliance with MCAZ regulations. Participating in tenders and responding to requests for proposals can enhance visibility and credibility. A clear regulatory filing strategy, including timely submission of necessary documentation and adherence to MCAZ's approval processes, is essential. Understanding the regulatory timeline and maintaining open communication with PCD will facilitate a successful partnership.

Frequently Asked Questions — Pharmaceutical AND Chemical

What products does Pharmaceutical AND Chemical import from India?

Pharmaceutical AND Chemical imports 2 pharmaceutical products across 2 categories. Top imports: Nifedipine ($1.5M), Tetracycline ($130.1K).

Who supplies pharmaceuticals to Pharmaceutical AND Chemical from India?

Pharmaceutical AND Chemical sources from 22 verified Indian suppliers. The primary supplier is Torrent Pharmaceuticals Limited (35.0% of imports, $5.9M).

What is Pharmaceutical AND Chemical's total pharmaceutical import value?

Pharmaceutical AND Chemical's total pharmaceutical import value from India is $1.7M, based on 35 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Pharmaceutical AND Chemical focus on?

Pharmaceutical AND Chemical imports across 2 categories. The largest: Cardiovascular (92.1%), Antibiotics (7.9%).

Get Full Pharmaceutical AND Chemical Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.